First Allied Advisory Services’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-3,455
| Closed | -$204K | – | 1205 |
|
|
2020
Q2 | $204K | Buy |
+3,455
| New | +$204K | 0.01% | 1000 |
|
|
2020
Q1 | – | Sell |
-4,332
| Closed | -$265K | – | 1141 |
|
|
2019
Q4 | $265K | Buy |
4,332
+38
| +0.9% | +$2.33K | 0.01% | 991 |
|
|
2019
Q3 | $252K | Sell |
4,294
-166
| -4% | -$9.74K | 0.01% | 987 |
|
|
2019
Q2 | $287K | Buy |
4,460
+95
| +2% | +$6.11K | 0.01% | 907 |
|
|
2019
Q1 | $347K | Sell |
4,365
-874
| -17% | -$69.5K | 0.01% | 804 |
|
|
2018
Q4 | $282K | Sell |
5,239
-173
| -3% | -$9.31K | 0.01% | 805 |
|
|
2018
Q3 | $281K | Sell |
5,412
-167
| -3% | -$8.67K | 0.01% | 938 |
|
|
2018
Q2 | $233K | Buy |
5,579
+311
| +6% | +$13K | 0.01% | 989 |
|
|
2018
Q1 | $228K | Buy |
5,268
+433
| +9% | +$18.7K | 0.01% | 988 |
|
|
2017
Q4 | $246K | Sell |
4,835
-301
| -6% | -$15.3K | 0.01% | 966 |
|
|
2017
Q3 | $259K | Sell |
5,136
-327
| -6% | -$16.5K | 0.01% | 885 |
|
|
2017
Q2 | $279K | Buy |
5,463
+494
| +10% | +$25.2K | 0.01% | 867 |
|
|
2017
Q1 | $200K | Sell |
4,969
-28
| -0.6% | -$1.13K | 0.01% | 1001 |
|
|
2016
Q4 | $239K | Buy |
+4,997
| New | +$239K | 0.01% | 902 |
|
|
2015
Q3 | – | Sell |
-5,808
| Closed | -$335K | – | 1093 |
|
|
2015
Q2 | $335K | Buy |
+5,808
| New | +$335K | 0.02% | 778 |
|
|
2014
Q4 | – | Sell |
-6,471
| Closed | -$250K | – | 1071 |
|
|
2014
Q3 | $250K | Sell |
6,471
-903
| -12% | -$34.9K | 0.02% | 814 |
|
|
2014
Q2 | $247K | Buy |
+7,374
| New | +$247K | 0.02% | 792 |
|